As of the latest SEC filings, Royalty Pharma plc (RPRX) is held by 442 institutional funds. The largest fund shareholder is New Perspective Fund (ANWPX), holding an estimated $942,406,579.53 in market value, representing 0.62% of its portfolio.
Funds holding Royalty Pharma plc (RPRX)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- RPRX
- CIK:
- 0001802768
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
ANWPX
New Perspective Fund
|
MF | Independent / Boutique | 0.62% | $942,406,579.53 | 19,645,749 | Mar 31, 2026 | May 28, 2026 |
|
CIRAX
Capital Income Builder
|
MF | Independent / Boutique | 0.34% | $430,003,966.43 | 8,584,627 | Apr 30, 2026 | Jun 26, 2026 |
|
AGTHX
Growth Fund of America
|
MF | Capital Group / American Funds | 0.08% | $254,211,561.04 | 5,501,224 | Feb 28, 2026 | Apr 27, 2026 |
|
MSGUX
GROWTH PORTFOLIO
|
MF | Morgan Stanley | 7.60% | $249,933,294.00 | 5,210,200 | Mar 31, 2026 | May 28, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.25% | $201,814,539.03 | 4,207,099 | Mar 31, 2026 | May 28, 2026 |
|
FCTDX
Strategic Advisers Fidelity U.S. Total Stock Fund
|
MF | Fidelity | 0.07% | $163,748,600.75 | 3,543,575 | Feb 28, 2026 | Apr 24, 2026 |
|
VFLO
VictoryShares Free Cash Flow ETF
|
ETF | Independent / Boutique | 2.35% | $144,775,330.83 | 3,018,039 | Mar 31, 2026 | May 28, 2026 |
|
LGOAX
Patient Opportunity Trust
|
MF | Independent / Boutique | 6.91% | $119,925,000.00 | 2,500,000 | Mar 31, 2026 | Jun 1, 2026 |
|
FDGFX
Fidelity Dividend Growth Fund
|
MF | Fidelity | 0.99% | $113,624,156.00 | 2,268,400 | Apr 30, 2026 | Jun 26, 2026 |
|
-
Transamerica Capital Growth
|
ETF | Transamerica | 8.51% | $107,432,981.91 | 2,144,799 | Apr 30, 2026 | Jun 18, 2026 |
|
-
Morgan Stanley Discovery Portfolio
|
ETF | Independent / Boutique | 8.14% | $91,183,342.77 | 1,900,841 | Mar 31, 2026 | May 28, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.22% | $91,019,051.43 | 1,969,683 | Feb 28, 2026 | Apr 24, 2026 |
|
CPODX
Morgan Stanley Insight Fund
|
MF | Morgan Stanley | 7.35% | $82,257,229.08 | 1,714,764 | Mar 31, 2026 | May 28, 2026 |
|
VHYAX
VANGUARD HIGH DIVIDEND YIELD INDEX FUND
|
ETF | Vanguard | 0.08% | $75,900,625.65 | 1,515,285 | Apr 30, 2026 | Jun 26, 2026 |
|
OEGAX
Invesco Discovery Mid Cap Growth Fund
|
MF | Invesco | 1.08% | $72,845,486.28 | 1,454,292 | Apr 30, 2026 | Jun 26, 2026 |
|
FSMDX
Fidelity Mid Cap Index Fund
|
MF | Fidelity | 0.14% | $71,329,662.70 | 1,424,030 | Apr 30, 2026 | Jun 26, 2026 |
|
IWR
iShares Russell Mid-Cap ETF
|
ETF | BlackRock / iShares | 0.15% | $70,609,105.71 | 1,471,943 | Mar 31, 2026 | May 28, 2026 |
|
FETKX
Fidelity Equity Dividend Income Fund
|
MF | Fidelity | 0.86% | $70,604,259.00 | 1,527,900 | Feb 28, 2026 | Apr 24, 2026 |
|
VHGEX
VANGUARD GLOBAL EQUITY FUND
|
MF | Vanguard | 1.01% | $70,542,811.17 | 1,470,561 | Mar 31, 2026 | May 28, 2026 |
|
FSPHX
Select Health Care Portfolio
|
MF | Fidelity | 1.12% | $69,315,000.00 | 1,500,000 | Feb 28, 2026 | Apr 24, 2026 |
|
-
Growth Fund
|
ETF | Capital Group / American Funds | 0.13% | $66,695,857.02 | 1,390,366 | Mar 31, 2026 | May 28, 2026 |
|
MPEGX
Discovery Portfolio
|
MF | Morgan Stanley | 8.67% | $64,439,492.13 | 1,343,329 | Mar 31, 2026 | May 28, 2026 |
|
FEIKX
Fidelity Equity-Income Fund
|
MF | Fidelity | 0.49% | $56,724,420.50 | 1,132,450 | Apr 30, 2026 | Jun 26, 2026 |
|
FMCHX
Fidelity Mid-Cap Stock Fund
|
MF | Fidelity | 0.59% | $51,975,137.15 | 1,037,635 | Apr 30, 2026 | Jun 26, 2026 |
|
IHE
iShares U.S. Pharmaceuticals ETF
|
ETF | BlackRock / iShares | 4.70% | $47,065,861.44 | 981,152 | Mar 31, 2026 | May 22, 2026 |
Advertisement (320x50)